by MM360 Staff | Jun 1, 2025 | Uncategorized
Source: CureToday articles Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer. Read More
by MM360 Staff | Jun 1, 2025 | Myeloma News
Source: Pharmacy Times articles Frank Qian, MD, MPH, discusses clinical considerations for omega-3 fatty acid therapy, such as the patient populations who may benefit most and important safety concerns. Read More
by MM360 Staff | Jun 1, 2025 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by MM360 Staff | Jun 1, 2025 | Myeloma News
Source: Pharmacy Times articles Frank Qian, MD, MPH, discusses the clinical indications, dosing strategies, and cardiovascular outcomes data for prescription omega-3 fatty acids, including the ongoing debate about EPA vs EPA-DHA formulations and the implications of...
by MM360 Staff | May 31, 2025 | Myeloma News
Source: Pharmacy Times articles Post Content Read More